US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...
New schizophrenia drug Cobenfy offers hope with fewer side effects targeting symptoms more effectively than traditional ...
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
Modalis Therapeutics has been awarded a rare paediatric disease designation by the US Food and Drug Administration (FDA) for ...
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback